Page 58 - TD-2-1
P. 58

Tumor Discovery                                                       LCP2 regulates melanoma progression




                         A                                   B



















                         C                                   D


















            Figure 4. Survival curves for high- and low-risk patients based on PIS. (A) Survival curves for DMFS in GSE65904 data set. (B) Survival curves for OS in
            GSE65904 data set. (C) Survival curves for DFS in TCGA data set. (D) Survival curves for OS in TCGA data set.
            PIS: Prognostic immune score; OS: Overall survival; DMFS: Distant metastasis-free survival; DFS: Disease-free survival; TCGA: The Cancer Genome Atlas.

              Furthermore, ten (BLNK,  CD81,  CLEC4E,  CPPED1,   identified prognostic gene and the specific TAL. We found
            IL18,  ISG20,  LCP2,  MGRN1,  RAB5C, and  TRIM32) out   that these identified prognostic genes were mainly correlated
                                                                       +
            of the 47 DEGs were statistically significant in predicting   with CD8  T cells, Treg cells, B cells, M0 macrophages, and
            the OS in univariate Cox proportional hazards models   natural killer cells. It is worth noting that the expression
                                                                                                     +
            and LASSO model in TCGA data set. Our results revealed   level of LCP2 was positively associated with CD8  T-cells.
            that elevated expression of CD81, IL18, MGRN1, RAB5C,   A few studies have shown that LCP2 was differentially
            and TRIM32 were associated with worse OS in melanoma   expressed in many different types of tumors and was
            patients, and elevated expression of BLNK, CLEC4E,   correlated with prognosis in numerous cancers [10-12] .
            CPPED1, ISG20,  and LCP2 were associated with better   Moreover, LCP2 was reported essential for normal T-cell
            prognosis in melanoma patients. The PIS was calculated   development and activation . In our present study, the
                                                                                     [14]
            based on the linear combination of the expression of   bioinformatics analyses revealed that high LCP2 expression
            selected ten genes, and the PIS was statistically significant   in melanoma patients was statistically significant for
            in predicting OS and DFS in melanoma patients after   predicting the OS in univariate Cox proportional hazards
            adjusting for several clinical covariates.
                                                               models in TCGA data set and was associated with better
              At present, numerous studies have reported the   prognosis in melanoma patients. In addition, we found
            important roles of various tumor-infiltrating immune cells   that LCP2 expression was significantly positively correlated
                                                                      +
            in melanoma [25-28] . To investigate the association between   with CD8  T-cells, indicating that LCP2 could be a potential
            the selected ten prognostic genes and tumor-infiltrating   immunotherapy target. Moreover, given the important role
            immune cells, we applied CIBERSORT to TCGA data set   of LCP2 in the immune system as reported in numerous
            and obtained 22 distinct TAL subsets, and used Spearman’s   published studies, we hence focused our efforts on
            rank correlation to analyze the correlation between each   investigating LCP2 in the subsequent studies. The in vivo


            Volume 2 Issue 1 (2023)                         8                           https://doi.org/10.36922/td.308
   53   54   55   56   57   58   59   60   61   62   63